
Chemical and Pharmaceutical Bulletin p. 1412 - 1414 (1996)
Update date:2022-09-26
Topics:
Satoh, Masato
Okamoto, Yoshinori
Koshio, Hiroyuki
Ohta, Mitsuaki
Nishida, Akito
Akuzawa, Shinobu
Miyata, Keiji
Mase, Toshiyasu
Semple, Graeme
A series of (3-substituted phenyl)urea analogues of the potent gastrin/cholecystokinin (CCK)-B receptor antagonist YM022 has been prepared. Structure activity relationship studies of this series suggested that a number of analogues retained good in vitro potency for gastrin/CCK-B receptor. In particular, the (3-amino substituted phenyl)urea derivatives (10-12) were more potent inhibitors of pentagastrin-induced gastric acid secretion in rats than YM022 on intraduodenal (i.d.) administration.
View MoreContact:+ 86 512 52491118
Address:1 Fuyu Road, Haiyu TownChangshu, Jiangsu, China
Chengdu Pukang Biotechnology Co., Ltd
Contact:+86-28-82550498
Address:No. 558 Rulin Road,Xinjin county,Chengdu city, China
shanghai jiuling chemical co.,ltd.
Contact:+86-21-50387295
Address:Zaozhuang Road, Pudong, Shanghai City. China
Beijing Mediking Biopharm Co., Ltd.
Contact:+86-10-89753524/81760121/81769521
Address:Hongxianghong Incubator, Beiqijia Town, Changping district, Beijing, China
Shanghai PengMo Biotechnology Co.,Ltd
website:http://www.pengmobio.lookchem.com
Contact:86-13052359378
Address:No.218 Hai Qu Road.Shanghai.China
Doi:10.1016/S0957-4166(03)00483-X
(2003)Doi:10.1055/s-2006-944222
(2006)Doi:10.1023/A:1023931428206
(2003)Doi:10.1055/s-1976-24162
(1976)Doi:10.1021/ja00439a074
(1976)Doi:10.1021/jo00427a031
(1977)